Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yun-Pi-Yi-Shen-Tong-Du-Tang
- Development stage
- Unknown
- Lead developer
- Prof. Chengping Wen
- Administration
- Oral
01
Overview
Yun-Pi-Yi-Shen-Tong-Du-Tang is an empirical Traditional Chinese Medicine (TCM) formula created by Prof. Chengping Wen, following the academic theory of "invigorating spleen and kidney, dredging collaterals" advanced by Zhu Liang Chun[2][3]. It is intended as a complementary treatment for ankylosing spondylitis (AS) and consists of 11 medicinal herbs, grouped according to TCM principles into "monarch" and "assistant" components. Major herbs include Atractylodes Lancea, Radix Astragali, Glycyrrhiza (to strengthen the spleen), Achyranthes Bidentata (to strengthen kidneys), Rhizoma Smilacis Glabrae, and Aconitum Carmichaeli (to dredge governor vessel). Network pharmacology and protein interaction analyses suggest the mechanism involves modulation of the TLR (Toll-like receptor) signaling pathway and T cell receptor signaling pathway, with key molecular targets identified such as JAK2, STAT3, HSP90AA1, TNF, and PTEN[2][3]. The formula contains over 350 active ingredients and has demonstrated efficacy and favorable safety for AS in retrospective clinical studies[2][3]. The developer is Prof. Chengping Wen, with formulation adjustments over more than two decades for clinical stability and minimized side effects.
- Brand names
- Yun-Pi-Yi-Shen-Tong-Du-Tang
- Other names
- Yun-Pi-Yi-Shen-Tong-Du-Tang
02
Targets
HSP90AA1 (Heat shock protein HSP90-alpha)JAK2 (Janus kinase 2)PTEN (Phosphatase and tensin homolog deleted on chromosome ten)STAT3 (Signal Transducer and Activator of Transcription 3)γδ TCR (T-cell receptor)TLR (Toll-like receptors)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Yun-Pi-Yi-Shen-Tong-Du-Tang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yun-Pi-Yi-Shen-Tong-Du-Tang.